JP2013519866A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013519866A5 JP2013519866A5 JP2012552129A JP2012552129A JP2013519866A5 JP 2013519866 A5 JP2013519866 A5 JP 2013519866A5 JP 2012552129 A JP2012552129 A JP 2012552129A JP 2012552129 A JP2012552129 A JP 2012552129A JP 2013519866 A5 JP2013519866 A5 JP 2013519866A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- subject
- serum creatinine
- possibility
- assigning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 80
- 229940109239 creatinine Drugs 0.000 claims 40
- 210000002966 serum Anatomy 0.000 claims 40
- 210000002700 urine Anatomy 0.000 claims 33
- 210000001124 body fluid Anatomy 0.000 claims 28
- 238000000034 method Methods 0.000 claims 26
- 230000003907 kidney function Effects 0.000 claims 23
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 16
- 208000033626 Renal failure acute Diseases 0.000 claims 16
- 201000011040 acute kidney failure Diseases 0.000 claims 16
- 238000003556 assay Methods 0.000 claims 16
- 208000012998 acute renal failure Diseases 0.000 claims 15
- 239000010839 body fluid Substances 0.000 claims 13
- 230000006378 damage Effects 0.000 claims 9
- 210000003734 kidney Anatomy 0.000 claims 9
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 claims 6
- 108010008150 Apolipoprotein B-100 Proteins 0.000 claims 6
- 102100040202 Apolipoprotein B-100 Human genes 0.000 claims 6
- 102000055006 Calcitonin Human genes 0.000 claims 6
- 108060001064 Calcitonin Proteins 0.000 claims 6
- 108010049003 Fibrinogen Proteins 0.000 claims 6
- 102000008946 Fibrinogen Human genes 0.000 claims 6
- 102000000743 Interleukin-5 Human genes 0.000 claims 6
- 108010002616 Interleukin-5 Proteins 0.000 claims 6
- 108010038501 Interleukin-6 Receptors Proteins 0.000 claims 6
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims 6
- 108010076501 Matrix Metalloproteinase 12 Proteins 0.000 claims 6
- 102000011721 Matrix Metalloproteinase 12 Human genes 0.000 claims 6
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims 6
- 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 claims 6
- 102100030758 Sex hormone-binding globulin Human genes 0.000 claims 6
- 108010000499 Thromboplastin Proteins 0.000 claims 6
- 102000002262 Thromboplastin Human genes 0.000 claims 6
- 102000036693 Thrombopoietin Human genes 0.000 claims 6
- 108010041111 Thrombopoietin Proteins 0.000 claims 6
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 6
- 229960004015 calcitonin Drugs 0.000 claims 6
- 229940012952 fibrinogen Drugs 0.000 claims 6
- 229940100602 interleukin-5 Drugs 0.000 claims 6
- 102000005666 Apolipoprotein A-I Human genes 0.000 claims 5
- 108010059886 Apolipoprotein A-I Proteins 0.000 claims 5
- 108010074051 C-Reactive Protein Proteins 0.000 claims 5
- 102100032752 C-reactive protein Human genes 0.000 claims 5
- 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 claims 5
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 claims 5
- 206010061481 Renal injury Diseases 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 230000007423 decrease Effects 0.000 claims 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- 230000003247 decreasing effect Effects 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 230000027455 binding Effects 0.000 claims 2
- 239000000090 biomarker Substances 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- 238000012959 renal replacement therapy Methods 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 230000002485 urinary effect Effects 0.000 claims 2
- 102000007592 Apolipoproteins Human genes 0.000 claims 1
- 108010071619 Apolipoproteins Proteins 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 1
- 108010036949 Cyclosporine Proteins 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 102000036675 Myoglobin Human genes 0.000 claims 1
- 108010062374 Myoglobin Proteins 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 claims 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 238000007675 cardiac surgery Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 229960001265 ciclosporin Drugs 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 238000012875 competitive assay Methods 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 210000004351 coronary vessel Anatomy 0.000 claims 1
- 229930182912 cyclosporin Natural products 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000002296 eclampsia Diseases 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000006870 function Effects 0.000 claims 1
- 230000024924 glomerular filtration Effects 0.000 claims 1
- 229910001385 heavy metal Inorganic materials 0.000 claims 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 1
- 229960001101 ifosfamide Drugs 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 201000011461 pre-eclampsia Diseases 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 201000001474 proteinuria Diseases 0.000 claims 1
- 238000012493 sandwich binding assay Methods 0.000 claims 1
- 238000013517 stratification Methods 0.000 claims 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 claims 1
- 229960001052 streptozocin Drugs 0.000 claims 1
- 229960001967 tacrolimus Drugs 0.000 claims 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 1
- 238000007631 vascular surgery Methods 0.000 claims 1
Applications Claiming Priority (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30201610P | 2010-02-05 | 2010-02-05 | |
| US30199210P | 2010-02-05 | 2010-02-05 | |
| US30197010P | 2010-02-05 | 2010-02-05 | |
| US30198510P | 2010-02-05 | 2010-02-05 | |
| US30204710P | 2010-02-05 | 2010-02-05 | |
| US30204810P | 2010-02-05 | 2010-02-05 | |
| US30203210P | 2010-02-05 | 2010-02-05 | |
| US30204510P | 2010-02-05 | 2010-02-05 | |
| US30196110P | 2010-02-05 | 2010-02-05 | |
| US30200910P | 2010-02-05 | 2010-02-05 | |
| US30201210P | 2010-02-05 | 2010-02-05 | |
| US30198110P | 2010-02-05 | 2010-02-05 | |
| US30203910P | 2010-02-05 | 2010-02-05 | |
| US61/302,012 | 2010-02-05 | ||
| US61/301,970 | 2010-02-05 | ||
| US61/301,992 | 2010-02-05 | ||
| US61/301,981 | 2010-02-05 | ||
| US61/302,045 | 2010-02-05 | ||
| US61/302,009 | 2010-02-05 | ||
| US61/301,961 | 2010-02-05 | ||
| US61/302,048 | 2010-02-05 | ||
| US61/301,985 | 2010-02-05 | ||
| US61/302,039 | 2010-02-05 | ||
| US61/302,032 | 2010-02-05 | ||
| US61/302,016 | 2010-02-05 | ||
| US61/302,047 | 2010-02-05 | ||
| PCT/US2011/023832 WO2011097541A2 (en) | 2010-02-05 | 2011-02-04 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015159649A Division JP6186400B2 (ja) | 2010-02-05 | 2015-08-12 | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013519866A JP2013519866A (ja) | 2013-05-30 |
| JP2013519866A5 true JP2013519866A5 (https=) | 2014-03-27 |
| JP5998055B2 JP5998055B2 (ja) | 2016-09-28 |
Family
ID=44356097
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012552129A Expired - Fee Related JP5998055B2 (ja) | 2010-02-05 | 2011-02-04 | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| JP2015159649A Expired - Fee Related JP6186400B2 (ja) | 2010-02-05 | 2015-08-12 | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015159649A Expired - Fee Related JP6186400B2 (ja) | 2010-02-05 | 2015-08-12 | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130230871A1 (https=) |
| EP (1) | EP2531622B1 (https=) |
| JP (2) | JP5998055B2 (https=) |
| CN (1) | CN102884205B (https=) |
| AU (1) | AU2011213686B2 (https=) |
| CA (1) | CA2788829A1 (https=) |
| EA (1) | EA201290627A1 (https=) |
| MX (1) | MX339765B (https=) |
| NZ (1) | NZ601648A (https=) |
| WO (1) | WO2011097541A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130324469A1 (en) * | 2010-12-09 | 2013-12-05 | The Brigham And Women's Hospital, Inc. | Fibrinogen and kidney damage |
| US10451636B2 (en) | 2014-04-09 | 2019-10-22 | The Regents Of The University Of California | Protein biomarkers for immune assessment and prediction of transplant rejection |
| ES2792227T3 (es) | 2014-09-26 | 2020-11-10 | Somalogic Inc | Predicción de evento de riesgo cardiovascular y usos de la misma |
| GB201511207D0 (en) * | 2015-06-25 | 2015-08-12 | Xvivo Perfusion Ab | Isolated organ evaluation and treatment |
| JP6232689B2 (ja) | 2015-06-25 | 2017-11-22 | 株式会社国際電気通信基礎技術研究所 | 多器官連関システムを基盤とした予測装置、及び予測プログラム |
| CN114594268A (zh) * | 2016-03-29 | 2022-06-07 | 无限生物制药公司 | 用以预防或治疗肾脏疾病的活性组分的候选物质的筛选装置和筛选方法 |
| EP3466446B1 (en) | 2016-03-29 | 2023-12-27 | Karydo Therapeutix, Inc. | Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo |
| CN121186362B (zh) * | 2025-11-25 | 2026-04-14 | 长兴固容生物科技有限公司 | 一种用于卵巢癌筛查、诊断的标志物组及其用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| JPH02275359A (ja) * | 1989-04-18 | 1990-11-09 | Teijin Ltd | 腎疾患の診断方法、診断試薬およびキット |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| AU1772992A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Crosstalk inhibitors and their uses |
| JP3290988B2 (ja) | 1991-04-11 | 2002-06-10 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | 多重リガンドを同時検出する新規接合体及び検定法 |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| FR2872579B1 (fr) * | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
| US20090258002A1 (en) * | 2005-02-01 | 2009-10-15 | Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services | Biomarkers for Tissue Status |
| US7608413B1 (en) * | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
| WO2007106781A2 (en) * | 2006-03-10 | 2007-09-20 | University Of Rochester | Ecg-based differentiation of lqt1 and lqt2 mutation |
| WO2008084331A2 (en) * | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
| WO2008031051A2 (en) * | 2006-09-08 | 2008-03-13 | United Therapeutics Corporation | Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers |
| EP2257813A4 (en) * | 2008-03-12 | 2011-11-02 | Univ Columbia | NGAL WITH HIGH MOLECULAR WEIGHT AS BIOMARKER FOR CHRONIC KIDNEY DISEASE |
-
2011
- 2011-02-04 US US13/577,244 patent/US20130230871A1/en not_active Abandoned
- 2011-02-04 EP EP11740470.7A patent/EP2531622B1/en not_active Not-in-force
- 2011-02-04 JP JP2012552129A patent/JP5998055B2/ja not_active Expired - Fee Related
- 2011-02-04 MX MX2012008955A patent/MX339765B/es active IP Right Grant
- 2011-02-04 WO PCT/US2011/023832 patent/WO2011097541A2/en not_active Ceased
- 2011-02-04 EA EA201290627A patent/EA201290627A1/ru unknown
- 2011-02-04 CN CN201180015316.2A patent/CN102884205B/zh not_active Expired - Fee Related
- 2011-02-04 NZ NZ601648A patent/NZ601648A/en not_active IP Right Cessation
- 2011-02-04 AU AU2011213686A patent/AU2011213686B2/en not_active Ceased
- 2011-02-04 CA CA2788829A patent/CA2788829A1/en not_active Abandoned
-
2015
- 2015-08-12 JP JP2015159649A patent/JP6186400B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013519095A5 (https=) | ||
| JP2014529073A5 (https=) | ||
| JP2013510321A5 (https=) | ||
| JP2013519866A5 (https=) | ||
| JP2012517594A5 (https=) | ||
| JP2013531240A5 (https=) | ||
| JP2016505143A5 (https=) | ||
| JP2014521088A5 (https=) | ||
| JP2013539861A5 (https=) | ||
| Husain-Syed et al. | Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery | |
| JP2012517592A5 (https=) | ||
| JP2013510322A5 (https=) | ||
| HRP20160733T1 (hr) | Postupci i pripravci za postavljanje dijagnoze i prognoze ozljede bubrega i bubrežne insuficijencije | |
| Teo et al. | Biomarkers in acute kidney injury (AKI) | |
| de Oliveira Neves et al. | Syndecan-1 in acute decompensated heart failure–Association with renal function and mortality– | |
| Hauser et al. | Prediction of acute renal allograft rejection by urinary monokine induced by IFN-γ (MIG) | |
| Rodrigues et al. | Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine | |
| US20170199204A1 (en) | Urine Biomarkers for Prediction of Recovery After Acute Kidney Injury: Proteomics | |
| HK1253858A1 (zh) | 用於肾损伤和肾衰竭的诊断及预後的方法和组合物 | |
| JP2013539030A5 (https=) | ||
| JP2021039112A5 (https=) | ||
| JP2012517593A5 (https=) | ||
| US11243217B2 (en) | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 | |
| De Loor et al. | Diagnosis of cardiac surgery-associated acute kidney injury: differential roles of creatinine, chitinase 3-like protein 1 and neutrophil gelatinase-associated lipocalin: a prospective cohort study | |
| MX2014002146A (es) | Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal. |